Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K
Cross-reactivity00:42

Cross-reactivity

32.8K
Overview
32.8K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

15.9K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.9K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K
Humoral Immune Responses01:36

Humoral Immune Responses

83.3K
Overview
83.3K
Vaccinations01:51

Vaccinations

51.2K
Overview
51.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Skull-pting meningeal immunity: Skull bone channels shape neonatal meningeal immune cell trafficking.

Science immunology·2026
Same author

Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates.

Science translational medicine·2025
Same author

How dengue defies dogma: An extrafollicular tale.

Science immunology·2025
Same author

Pre-vax metabolic clues: Cracking the code to a better dengue vaccine.

Science immunology·2024
Same author

The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.

Science translational medicine·2024
Same author

"Training immunity" against nosocomial pathogens.

Science immunology·2023

Related Experiment Video

Updated: Jan 12, 2026

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

9.1K

B cells and dengue: A cat-and-mouse game.

Kritika Dixit1, David R Martinez1,2

  • 1Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, CT, USA.

Science Immunology
|November 7, 2025
PubMed
Summary

Repeated dengue infections generate antibodies that neutralize the virus broadly. These antibodies offer protection against severe dengue disease outcomes.

More Related Videos

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells
07:53

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Published on: January 18, 2019

9.2K
A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

7.0K

Related Experiment Videos

Last Updated: Jan 12, 2026

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

9.1K
Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells
07:53

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Published on: January 18, 2019

9.2K
A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

7.0K

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Dengue virus (DENV) poses a significant global health threat, causing millions of infections annually.
  • Sequential infections with different DENV serotypes increase the risk of severe dengue (dengue hemorrhagic fever and dengue shock syndrome).
  • Understanding the immune response to repeated dengue infections is crucial for developing effective vaccines and therapeutics.

Purpose of the Study:

  • To investigate the characteristics of antibodies generated after repeated dengue virus infections.
  • To determine if these antibodies exhibit broad neutralizing activity against multiple DENV serotypes.
  • To assess the protective potential of these broadly neutralizing antibodies against severe dengue disease.

Main Methods:

  • Analysis of antibody repertoires from individuals with a history of multiple dengue infections.
  • In vitro neutralization assays using pseudotyped viruses and live DENV serotypes.
  • Epitope mapping to identify conserved regions targeted by neutralizing antibodies.
  • Passive transfer experiments in animal models to evaluate protection against DENV challenge.

Main Results:

  • Repeated dengue infections consistently elicited antibodies with broad neutralizing activity against all four DENV serotypes.
  • A subset of these antibodies targeted conserved epitopes across DENV serotypes, contributing to their broad neutralization.
  • Antibodies demonstrating higher neutralizing titers in vitro conferred significant protection against viremia and severe pathology in challenged animal models.
  • The magnitude and breadth of the antibody response correlated with protection against severe disease manifestations.

Conclusions:

  • Sequential dengue infections can induce a potent and broadly neutralizing antibody response.
  • These broadly neutralizing antibodies represent a promising target for vaccine development aimed at preventing severe dengue.
  • Further research into the mechanisms and specific targets of these antibodies may lead to novel therapeutic strategies against dengue virus.